January 9, 2012

HELIX BIOPHARMA CORP. APPOINTS JACK KAY AS CHAIRMAN OF THE BOARD AND PROFESSOR KAZIMIERZ ROSZKOWSKI- ŚLIŻ AS EUROPEAN MEDICAL DIRECTOR (PDF)

AURORA, Ontario, January 9, 2012 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: HBP) (the “Company” or “Helix”) announces that Mr. Jack M. Kay has been appointed as Chairman of the Board. Mr. Kay replaces Dr. Donald H. Segal in this capacity. Dr. Segal remains as Helix’s Chief Executive Officer and a director of the Company.